Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719)
HKEX:0719
Holding HK:0719?
Track your performance easily
0719 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$4.80 - HK$8.05
Previous CloseHK$5.83
Volume1.74M
Average Volume (3M)2.25M
Market Cap
HK$9.65B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)8.1
Beta0.62
Next Earnings
Mar 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 04, 2024Dividend Yield5.17%
Share Statistics
EPS (TTM)0.72
Shares OutstandingN/A
10 Day Avg. Volume1,230,840
30 Day Avg. Volume2,253,393
Standard Deviation0.16
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Shandong Xinhua Pharmaceutical Company Limited Class H News
PremiumCompany Announcements
Shandong Xinhua Announces Major Fish Oil Acquisition
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical EGM Approves Key Resolution
PremiumCompany Announcements
Shandong Xinhua’s Subsidiary Gains Approval for Azithromycin
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Key Drug Approval
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Key Drug ApprovalPremiumCompany Announcements
Shandong Xinhua Gains FDA Approval for Key Drug
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Announces December EGMPremiumCompany Announcements
Shandong Xinhua Pharma Secures Key Drug ApprovalOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.70% Mutual Funds
― Other Institutional Investors
99.16% Public Companies and
Individual Investors
0719 FAQ
What was Shandong Xinhua Pharmaceutical Company Limited Class H’s price range in the past 12 months?
Shandong Xinhua Pharmaceutical Company Limited Class H lowest stock price was HK$4.80 and its highest was HK$8.05 in the past 12 months.
What is Shandong Xinhua Pharmaceutical Company Limited Class H’s market cap?
Currently, no data Available
When is Shandong Xinhua Pharmaceutical Company Limited Class H’s upcoming earnings report date?
Shandong Xinhua Pharmaceutical Company Limited Class H’s upcoming earnings report date is Mar 26, 2025 which is in 93 days.
How were Shandong Xinhua Pharmaceutical Company Limited Class H’s earnings last quarter?
Shandong Xinhua Pharmaceutical Company Limited Class H released its earnings results on Oct 29, 2024. The company reported HK$0.126 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.126.
Is Shandong Xinhua Pharmaceutical Company Limited Class H overvalued?
According to Wall Street analysts Shandong Xinhua Pharmaceutical Company Limited Class H’s price is currently Overvalued.
Does Shandong Xinhua Pharmaceutical Company Limited Class H pay dividends?
Shandong Xinhua Pharmaceutical Company Limited Class H pays a Annually dividend of HK$0.027 which represents an annual dividend yield of 5.17%. See more information on Shandong Xinhua Pharmaceutical Company Limited Class H dividends here
What is Shandong Xinhua Pharmaceutical Company Limited Class H’s EPS estimate?
Shandong Xinhua Pharmaceutical Company Limited Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shandong Xinhua Pharmaceutical Company Limited Class H have?
Shandong Xinhua Pharmaceutical Company Limited Class H has 195,000,000 shares outstanding.
What happened to Shandong Xinhua Pharmaceutical Company Limited Class H’s price movement after its last earnings report?
Shandong Xinhua Pharmaceutical Company Limited Class H reported an EPS of HK$0.126 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.449%.
Which hedge fund is a major shareholder of Shandong Xinhua Pharmaceutical Company Limited Class H?
Currently, no hedge funds are holding shares in HK:0719
---
Shandong Xinhua Pharmaceutical Company Limited Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.66%
12-Months-Change
Fundamentals
Return on Equity
9.54%
Trailing 12-Months
Asset Growth
15.01%
Trailing 12-Months
Company Description
Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.
---
Technical Analysis
Eminence Enterprise Limited
―
Shenguan Holdings (Group) Limited
―
Khoon Group Limited
―
China Dredging Environment Protection Holdings Limited
―
---